- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
NextCure (NASDAQ:NXTC), Quotes and News Summary
NextCure (NASDAQ: NXTC)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-04 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.670 | -0.740 | -0.0700 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
NextCure Questions & Answers
You can purchase shares of NextCure (NASDAQ: NXTC) through any online brokerage.
Other companies in NextCure’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Celcuity (NASDAQ:CELC), Immuneering (NASDAQ:IMRX), Atossa Therapeutics (NASDAQ:ATOS) and Humanigen (NASDAQ:HGEN).
The latest price target for NextCure (NASDAQ: NXTC) was reported by Piper Sandler on Monday, May 23, 2022. The analyst firm set a price target for 13.00 expecting NXTC to rise to within 12 months (a possible 188.89% upside). 3 analyst firms have reported ratings in the last year.
The stock price for NextCure (NASDAQ: NXTC) is $4.5 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for NextCure.
NextCure’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for NextCure.
NextCure is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.